Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis

OBJECTIVE: To ascertain if etoricoxib increases the risk of gastrointestinal adverse events (GAEs) compared with placebo, diclofenac, and naproxen in the treatment of patients with osteoarthritis (OA) or rheumatoid arthritis (RA). METHODS: Studies were searched in MEDLINE, EMBASE, Cochrane Central R...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xiaoting, Tian, Mei, Zhang, Wei, Mei, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761870/
https://www.ncbi.nlm.nih.gov/pubmed/29320568
http://dx.doi.org/10.1371/journal.pone.0190798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761870/
https://www.ncbi.nlm.nih.gov/pubmed/29320568
http://dx.doi.org/10.1371/journal.pone.0190798

Ejemplares similares